Anti-Tumor Necrosis Factor Treatment in the Management of Pediatric Noninfectious Uveitis: Infliximab Versus Adalimumab-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Anti-Tumor Necrosis Factor Treatment in the Management of Pediatric Noninfectious Uveitis: Infliximab Versus Adalimumab

Published:2021-05-01 Issue:4 Volume:37 Page:236-240
ISSN:1080-7683
Container-title:Journal of Ocular Pharmacology and Therapeutics
language:en
Short-container-title:Journal of Ocular Pharmacology and Therapeutics

Author:

Ucan Gunduz Gamze¹,Yalcinbayir Ozgur¹,Cekic Sukru²,Yildiz Meral¹,Kilic Sara S.³

Affiliation:

1. Department of Ophthalmology, Uludag University School of Medicine, Bursa, Turkey.

2. Uludag University School of Medicine, Pediatric Allergy and Clinical Immunology, Bursa, Turkey.

3. Uludag University School of Medicine, Pediatric Immunology and Rheumatology, Bursa, Turkey.

Publisher

Mary Ann Liebert Inc

Subject

Pharmacology (medical),Pharmacology,Ophthalmology

Link

https://www.liebertpub.com/doi/pdf/10.1089/jop.2020.0081

Reference15 articles.

1. Management of chronic pediatric uveitis

2. Prevalence of Noninfectious Uveitis in the United States

3. Comparative efficacy between adalimumab and infliximab in the treatment of non-infectious intermediate uveitis, posterior uveitis, and panuveitis: a retrospective observational study of 107 patients

4. Medication use in juvenile uveitis patients enrolled in the Childhood Arthritis and Rheumatology Research Alliance Registry

Cited by 10 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Efficacy of Adalimumab in pediatric non-infectious uveitis with apparent and non-apparent anterior uveitis;2024-06-24

2. Taiwan ocular inflammation society consensus recommendations for the management of juvenile idiopathic arthritis-associated uveitis;Journal of the Formosan Medical Association;2024-02

3. Update on the systemic management of noninfectious uveitis in children and adolescents;Survey of Ophthalmology;2024-01

4. Treatment with Biologic Drugs in Pediatric Behçet’s Disease: A Comprehensive Analysis of the Published Data;BioDrugs;2023-06-29

5. Comparison of infliximab with adalimumab for the treatment of non-infectious uveitis: a systematic review and meta-analysis;BMC Ophthalmology;2023-05-29

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3